Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
30.78
+0.14 (0.46%)
Nov 21, 2024, 10:44 AM EST - Market open
Akero Therapeutics Market Cap
Akero Therapeutics has a market cap or net worth of $2.15 billion as of November 21, 2024. Its market cap has increased by 167.73% in one year.
Market Cap
2.15B
Enterprise Value
1.39B
1-Year Change
167.73%
Ranking
Category
Stock Price
$30.78
Market Cap Chart
Since June 20, 2019, Akero Therapeutics's market cap has increased from $495.47M to $2.15B, an increase of 333.54%. That is a compound annual growth rate of 31.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 2.17B | 66.50% |
| Dec 29, 2023 | 1.30B | -49.24% |
| Dec 30, 2022 | 2.56B | 247.29% |
| Dec 31, 2021 | 737.89M | -17.63% |
| Dec 31, 2020 | 895.82M | 41.33% |
| Dec 31, 2019 | 633.86M | 27.93% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Omnicell | 2.13B |
| Amphastar Pharmaceuticals | 2.12B |
| Centessa Pharmaceuticals | 2.12B |
| Addus HomeCare | 2.12B |
| Ligand Pharmaceuticals | 2.11B |
| Astrana Health | 1.99B |
| Mirum Pharmaceuticals | 1.99B |
| Evotec SE | 1.97B |